VASCULAR ACCESS SITE PHLEBITIS

VASCULAR ACCESS SITE PHLEBITIS was reported 4 times

VASCULAR ACCESS SITE PHLEBITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Autologous Cellular Immunotherapy [EPC] 2 0.0003
1 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 2 0.0001
2 General Anesthetic [EPC] 1 0.0000
3 Expectorant [EPC] 2 0.0000